Sökning: id:"swepub:oai:DiVA.org:uu-472806" >
Plan robustness and...
Plan robustness and RBE influence for proton dose painting by numbers for head and neck cancers
-
- Almhagen, Erik (författare)
- Uppsala universitet,Medicinsk strålningsvetenskap,The Skandion Clinic, Uppsala, Sweden
-
- Dasu, Alexandru, 1972- (författare)
- Uppsala universitet,Medicinsk strålningsvetenskap,The Skandion Clinic, Uppsala, Sweden
-
- Johansson, Silvia (författare)
- Uppsala universitet,Experimentell och klinisk onkologi
-
visa fler...
-
Traneus, Erik (författare)
-
- Ahnesjö, Anders, 1953- (författare)
- Uppsala universitet,Medicinsk strålningsvetenskap
-
visa färre...
-
(creator_code:org_t)
- Elsevier, 2023
- 2023
- Engelska.
-
Ingår i: Physica medica (Testo stampato). - : Elsevier. - 1120-1797 .- 1724-191X. ; 115, s. 103157-
- Relaterad länk:
-
https://doi.org/10.1...
-
visa fler...
-
https://uu.diva-port... (primary) (Raw object)
-
https://urn.kb.se/re...
-
https://doi.org/10.1...
-
visa färre...
Abstract
Ämnesord
Stäng
- PurposeTo investigate the feasibility of dose painting by numbers (DPBN) with respect to robustness for proton therapy for head and neck cancers (HNC), and to study the influence of variable RBE on the TCP and OAR dose burden.Methods and materialsData for 19 patients who have been scanned pretreatment with PET-FDG and subsequently treated with photon therapy were used in the study. A dose response model developed for photon therapy was implemented in a TPS, allowing DPBN plans to be created. Conventional homogeneous dose and DPBN plans were created for each patient, optimized with either fixed RBE = 1.1 or a variable RBE model. Robust optimization was used to create clinically acceptable plans. To estimate the maximum potential loss in TCP due to actual SUV variations from the pre-treatment imaging, we applied a test case with randomized SUV distribution.ResultsRegardless of the use of variable RBE for optimization or evaluation, a statistically significant increase (p < 0.001) in TCP was found for DPBN plans as compared to homogeneous dose plans. Randomizing the SUV distribution decreased the TCP for all plans. A correlation between TCP increase and variance of the SUV distribution and target volume was also found.ConclusionDPBN for protons and HNC is feasible and could lead to a TCP gain. Risks associated with the temporal variation of SUV distributions could be mitigated by imposing minimum doses to targets. The correlation found between TCP increase and SUV variance and target volume may be used for patient selection.
Ämnesord
- MEDICIN OCH HÄLSOVETENSKAP -- Klinisk medicin -- Cancer och onkologi (hsv//swe)
- MEDICAL AND HEALTH SCIENCES -- Clinical Medicine -- Cancer and Oncology (hsv//eng)
Nyckelord
- RBE
- Radiobiology
- Proton Therapy
- Dose Painting
- Head and Neck Cancer
- Medicinsk radiofysik
- Medical Radiophysics
Publikations- och innehållstyp
- ref (ämneskategori)
- art (ämneskategori)
Hitta via bibliotek
Till lärosätets databas